GILD Watch for Breakout here! TRUMP PUMP! Gild on high watch with Trump receiving REMDISIVIR treatment and Trump reporting he is feeling better and expected to be discharged and return soon. Which means we could see green market this week. GILD is at my support zone and we have a gap up to fill at $69 If we can hold above $61.62 we could see a move back up to fill that gap. Good opportunity to long here!by jUiCE_Trades1
Gilead Sciences Stock AnalysisBased on Technical Analysis the best option is to hold and wait the end of the price retracement before going long. Trump has been treated with Gilead Sciences remdesivir.by Mauriello3
On 7 years support, they are giving Remdesivir DT. 4.38% Div.Buy the support sell the resistance.Longby HI_DUTENGIN7
$GILD - Needs to stabilize above 63.13Potential Long entry above 63.2 (Closing price) Not for any advise Just an Idea, by Samuel12_19801
bad new if it drops below support/good news for SHORTGood news to SHORTERS onlyShortby luckysavvytrader555
$GILD trend reversal ? it maybe a trend reversal for $GILD the stock has good fundamentals ,, and the company was providing COVID-19 medicine for free ,, now they put a price for each patient treatment course nearly 2000$ so it maybe will push the company earnings . it is not a buy or sell recommendation ,, im here to share my ideas . by Talal_BUpdated 6
DOWN from Symmetrical Triangle I do not go short but this could go down a bit more. Symmetrical Triangle can break either way. This one broke to the downside If bottom not formed here then next Possible target down may be 60.25by lauraleaUpdated 17171
GILD: need to break the $67 barrierwe're still holding GILD and now it's making another attempt at recovering from the recent drop we need to break the $67 and stay above it for couple of sessions - with strong volume - to flag a proper recovery - the prior attempt for a breakout failed - this time there's some momentum and demand - but still light. we'll seeLongby RedKTrader0
Gilead sciences - long term investmentDear traders and followers, It’s time again for one of our popular stock analytics. Today we take a closer look at Gilead Sciences The California-based pharmaceutical and biotechnology company offers a very attractive mix of Corona’s special economy, a bit of takeover fantasy and a moderate evaluation. The drug Remdesivir, which is approved for Corona treatment, is expected to generate sales of almost two billion dollars this year, which according to Bloomberg’s 2021 estimate should increase by another 20 percent. The 2021 KGV of eleven is among the ten lowest in the entire Nasdaq 100. No wonder there is speculation that AstraZeneca wants to take over Gilead, given that both groups are complementary in their focus areas. If this is not enough as a reason to buy, the share traded around 40 percent below the record high looks at the nice lower reversal, which can be seen in the chart picture along with the medium-term upward trend. Technical view: Market has formed a triangle formation since 2014 (after a strong up rally) and broke out of it at the beginning of March. The price is atm within correction movement which is expected to end at the drawn buy area at around 70 $. We´ve set our buy orders at this point. Feel free to leave a comment or to share your ideas in the comments section Please hit the like button if you share or like this idea. Thanks for your support !Longby DK_InvestmentUpdated 8812
Swing trade idea on Gilead SciencesI don't actually like Gilead Sciences for a long-term buy and hold, because its earnings have been in a long-term downtrend. There's a case to be made for a swing trade, however. Gilead is now sitting on trend line support in a fairly high-volume range. It's about 25% below its median forward P/E and forward P/S for the last three years. It has been selling off on news that remdesivir has shown no therapeutic value for Covid-19, but it may now rally for a while on news that the FDA has approved it for emergency use in moderate Covid patients anyway.Longby ChristopherCarrollSmith1116
GILEAD SCIENCES (GILD) buy signals on D1.GILEAD SCIENCES, daily timeframe: Support line + Side of Bollinger bands + Nice discount + Divergence + HammerLongby Dmitry_Nikolaev446
GIILD 12.08.20 LongAsset and Time frame -GILD,4H Entry Price -68.99 Exit(Stop Loss) -67.19 Exit(Take Profit) -75.55 Technical Analysis -Price reacted to the -27.2 for the second time(less favorable) but had a hard time going even more downwards, on the 4H chart price has left the tunnel with a gap up, on weekly chart price is sitting on the 100SMA, also RSI divergence What can be improved - Conclusion & End of Trade -Longby AviranyUpdated 2
GILD starting to look niceThis has pulled right back into the Demand Zone. Looking to start buying hereLongby ghostdiggUpdated 4
Remdesivir News is GOOD for Gilead - 4HR ChartHearing chatter down the grape vine about Remdesivir again, watch for the bounce back-up on GILD. This was just trading in the $80 dollar range so keep an eye out for that move on the news. Longby AaronX2
Ahmed Jarmouni Given the good announcement, it is advisable to buy this share But beware, she has to break higher than yesterday's fence: Gilead Sciences, Inc GILD announced Monday it was seeking complete FDA approval for its drug Remdesivir, which is being used in the treatment of COVID-19.Longby JALTRADING0